Levin Capital Strategies’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,942
Closed -$514K 212
2024
Q3
$514K Buy
10,942
+4,000
+58% +$188K 0.05% 113
2024
Q2
$375K Buy
+6,942
New +$375K 0.04% 132